S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-0.15%) $77.99
Gas
(0.37%) $2.15
Gold
(0.06%) $2 310.10
Silver
(0.36%) $26.79
Platinum
(0.09%) $966.20
USD/EUR
(-0.34%) $0.929
USD/NOK
(-1.10%) $10.87
USD/GBP
(-0.14%) $0.797
USD/RUB
(0.52%) $91.61

Sanntidsoppdatering for Vectura Group PLC [VEC.L]

Børs: LSE Industri: Pharmaceuticals, Biotechnology & Life Sciences
Sist oppdatert1 jan 1970 @ 01:00

0.00% £ 164.80

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees...

Stats
Dagens volum 203 762
Gjennomsnittsvolum 8.30M
Markedsverdi 0.00
EPS £-0.00834 ( 2019-06-29 )
Last Dividend £19.00 ( 2021-06-01 )
Next Dividend £0 ( N/A )
P/E 0.0800
ATR14 £0 (0.00%)

Vectura Group PLC Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Vectura Group PLC Økonomi

Annual 2020
Omsetning: £190.60M
Bruttogevinst: £101.40M (53.20 %)
EPS: £0.188
FY 2020
Omsetning: £190.60M
Bruttogevinst: £101.40M (53.20 %)
EPS: £0.188
FY 2019
Omsetning: £178.30M
Bruttogevinst: £95.30M (53.45 %)
EPS: £-0.0340
FY 2018
Omsetning: £160.50M
Bruttogevinst: £98.90M (61.62 %)
EPS: £-0.143

Financial Reports:

No articles found.

Vectura Group PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Vectura Group PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.35 - Potential for dividend initiation, but uncertain (13.08%)
Information
First Dividend £6.50 2019-10-14
Last Dividend £19.00 2021-06-01
Next Dividend £0 N/A
Payout Date 2021-06-11
Next Payout Date N/A
# dividends 2 --
Total Paid Out £25.50 --
Avg. Dividend % Per Year 0.00% --
Score 2.69 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.35
Div. Directional Score 8.24 --
Next Divdend (Est)
(2025-10-01)
£0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
2.69
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2019 £0 0.00%
2020 £0 0.00%
2021 £0 0.00%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TON.L Dividend Knight 2023-06-01 Annually 32 1.80%
LTHM.L Dividend Knight 2023-08-03 Semi-Annually 33 0.87%
COA.L Dividend Knight 2023-10-19 Annually 33 1.79%
ROR.L Dividend King 2023-08-17 Semi-Annually 32 1.43%
HHI.L Dividend King 2023-09-14 Quarterly 25 3.58%
AUTO.L Dividend Knight 2023-08-24 Annually 9 0.79%
VLX.L Dividend Knight 2023-07-20 Sporadic 32 0.82%
MRCH.L Dividend King 2023-07-06 Quarterly 53 3.07%
DIVI.L Dividend Knight 2023-09-28 Quarterly 14 1.99%
SHOE.L Dividend Knight 2023-07-13 Annually 10 2.57%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.6421.50010.0010.00[0 - 0.5]
returnOnAssetsTTM0.1841.2003.874.65[0 - 0.3]
returnOnEquityTTM0.2541.5008.2910.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.590.80010.008.00[1 - 3]
quickRatioTTM0.9230.8009.287.42[0.8 - 2.5]
cashRatioTTM0.9231.5005.998.98[0.2 - 2]
debtRatioTTM0.00631-1.5009.89-10.00[0 - 0.6]
interestCoverageTTM1 314.001.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM0.03802.009.9910.00[0 - 30]
freeCashFlowPerShareTTM0.01812.009.9910.00[0 - 20]
debtEquityRatioTTM0.00771-1.5009.97-10.00[0 - 2.5]
grossProfitMarginTTM0.5321.0004.474.47[0.2 - 0.8]
operatingProfitMarginTTM0.6891.00010.0010.00[0.1 - 0.6]
cashFlowToDebtRatioTTM5.901.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.2860.800-1.425-1.140[0.5 - 2]
Total Score12.14

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM8.781.0009.210[1 - 100]
returnOnEquityTTM0.2542.508.9010.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.01812.009.9910.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.03802.009.9910.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1301.0009.250[0.1 - 0.5]
Total Score4.35

Vectura Group PLC

Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees. The firm's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.